Will Lewis

Chair and CEO, Insmed

Bridgewater, New Jersey

About

Will Lewis is the Chair and Chief Executive Officer of Insmed, a biopharmaceutical company headquartered in Bridgewater, New Jersey. His legal name in company filings is William H. Lewis. He has been CEO since September 2012 and Chair of the board since November 2018. Before Insmed he co-founded Aegerion Pharmaceuticals, where he served as President and Chief Financial Officer.

Lewis holds a B.A. from Oberlin College and an M.B.A. and J.D. from Case Western Reserve University. He worked in the U.S. Government Foreign Service from 1989 to 1992 and at JP Morgan Chase from 1995 to 2000. He then worked at Robertson Stephens Capital from 2000 to 2002 and Wells Fargo from 2002 to 2004, before helping start Aegerion in 2005. He advised the Insmed board from June to September 2012 before taking the CEO role. Other biotech and pharmaceutical chief executives with pages on Whoo include Michael Morrissey of Exelixis and Reshma Kewalramani of Vertex Pharmaceuticals.

Whoo compiled this page from public sources: Insmed 2026 proxy statement (SEC), Insmed Q3 2026 results filing (SEC), Insmed Form 10-K, 2025 (SEC). It is not affiliated with or endorsed by Will Lewis. Are you Will Lewis? Claim this page, or write to [email protected] to correct or remove it. Last updated: 2026-11-18.

Want a page like this? Create yours from your résumé.

Experience

Chair and Chief Executive Officer — Insmed


2012 – Present | Bridgewater, New Jersey

  • President and CEO from 2012 to 2018; Chair and CEO since November 2018

Co-founder, President and Chief Financial Officer — Aegerion Pharmaceuticals


2005 – 2011

Wells Fargo & Co.


2002 – 2004

Robertson Stephens Capital


2000 – 2002

JP Morgan Chase & Co.


1995 – 2000

U.S. Government Foreign Service


1989 – 1992

Education

MBA and JD — Case Western Reserve University

BA — Oberlin College

Projects